Invention Grant
![Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors](/docs/US/2015-07-07/US09073922B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors
- Patent Title (中): 吡咯并[2,3-B]吡啶CDK9激酶抑制剂
-
Application No.: US14207886Application Date: 2014-03-13
-
Publication No.: US09073922B2Publication Date: 2015-07-07
- Inventor: Jianchun Gong , Zhi-Fu Tao , Thomas D. Penning , Andrew J. Souers , Yunsong Tong , Guidong Zhu
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie, Inc.
- Current Assignee: AbbVie, Inc.
- Current Assignee Address: US IL North Chicago
- Agent Chanqxia Sun
- Main IPC: C07D401/10
- IPC: C07D401/10 ; A61K31/437 ; A61K31/4353 ; C07D471/04 ; A61K31/497 ; A61K31/5377
![Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors](/abs-image/US/2015/07/07/US09073922B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are compounds of Formula (IIIa), wherein R1, R2, R3, X1, X2, X3, X4, X5, have any of the values defined therefore in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (IIIa).
Public/Granted literature
- US20140275027A1 PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS Public/Granted day:2014-09-18
Information query
